Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion type Assertion NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_head.
- NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion description "[In conclusion, the prevalence of APC resistance (and FVL) is increased in patients with RVO compared to controls, but the effect is only moderate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_provenance.
- NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion evidence source_evidence_literature NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_provenance.
- NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion SIO_000772 18449423 NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_provenance.
- NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion wasDerivedFrom befree-20140225 NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_provenance.
- NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_assertion wasGeneratedBy ECO_0000203 NP556671.RAaHu-djG3S6WqAxFOqkkmHqT-xu5R7VUaJaNKuRhu0F4130_provenance.